Similarities and differences: Between body dysmorphic disorder and other disorders

Psychiatric Annals

Volumn 34, Issue 12, 2004, Pages 927-933

  Allen, Andrea ^a   Hollander, Eric ^a,b,c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Department of Psychiatry ^*

^c Seaver NY Autism Ctr of Excellence   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; PIMOZIDE; SEROTONIN UPTAKE INHIBITOR;

ANOREXIA NERVOSA; ANXIETY DISORDER; BEHAVIOR DISORDER; BEHAVIOR THERAPY; BODY DYSMORPHIC DISORDER; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; COMPARATIVE STUDY; DELUSION; DEPRESSION; DISEASE CLASSIFICATION; DISTRESS SYNDROME; DRUG EFFICACY; DRUG RESPONSE; EATING DISORDER; FUNCTIONAL DISEASE; GROOMING; HEALTH SURVEY; HUMAN; HYPOCHONDRIASIS; LIFE EVENT; MEDICAL RESEARCH; MEDICAL SPECIALIST; MENTAL DISEASE; MENTAL PATIENT; OBSESSIVE COMPULSIVE DISORDER; PATIENT CARE; PLASTIC SURGERY; POPULATION RESEARCH; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOLOGY; REVIEW; RISK ASSESSMENT; SOCIAL PHOBIA; SOCIAL PSYCHOLOGY; SYMPTOM; TRICHOTILLOMANIA;

EID: 12744254784     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-20041201-15     Document Type: Review

References (35)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. [text revision]. Washington, DC: American Psychiatric Publishing; 2000.
2. Hollander E. Obsessive-compulsive spectrum disorders: an overview. Psychiatr Ann. 1993;23(7):355-358.
3. Phillips KA, Gunderson CG, Mallya G, McElroy SL, Carter W. A comparison study of body dysmorphic disorder and obsessive-compulsive disorder. J Clin Psychiatry. 1998;59(11):568-575.
4. Simeon D, Hollander E, Stein DJ, Cohen L, Aronowitz B. Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder. Am J Psychiatry. 1995;152(8):1207-1209.
5. Eisen JL, Phillips KA, Rasmussen SA. Obsessions and delusions: the relationship between obsessive compulsive disorder and the psychotic disorders. Psychiatr Ann. 1999;29(9):515-522.
6. Phillips KA, McElroy SL, Keck PE, Pope HG, Hudson JI. A comparison of delusional and non-delusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull. 1994;30(2):179-186.
7. Foa EB, Jenike M, Kozak MJ, et al. Obsessive-compulsive disorder. In: Widiger TA, Frances AJ, Pincus HA, Ross R, First MB, Davis WW, eds. DSM-IV Sourcebook. Vol 2. Washington, DC: American Psychiatric Publishing; 1996:549-575.
8. Eisen JL, Rasmussen SA. Obsessive compulsive disorder with psychotic features. J Clin Psychiatry. 1993;54(10):373-379.
9. Eisen JL, Rasmussen SA, Phillips KA, et al. Insight and treatment outcome in obsessive-compulsive disorder. Compr Psychiatry. 2001;42(6):494-497.
10. Lelliott PT, Noshirvani HF, Basoglu M, Marks IM, Monteiro WO. Obsessive-compulsive beliefs and treatment outcome. Psychol Med. 1988;18(3):697-702.
11. Hollander E, Allen A, Kwon J, et al. Clomipramine vs. desipramine crossover trial in body dysmorphic disorder. Arch Gen Psychiatry. 1999;56(11):1033-1039.
12. Phillips KA, Albertini RS, Rasmussen SA. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psych. 2002;59(4):381-388.
13. Phillips KA. A placebo controlled trial of pimozide augmentation of fluoxetine in body dysmorphic disorder. Presented at: American College of Neuropsychopharmacology 41st Annual Meeting; December 8-12, 2002; San Juan, Puerto Rico.
14. O'Sullivan RL, Mansueto CS, Lerner EA, Miguel EC. Characterization of trichotillomania. A phenomenological model with clinical relevance to obsessive-compulsive spectrum disorders. Psychiatr Clin North Am. 2000;23(3):587-604.
15. Cohen LJ, Stein DJ, Simeon D, et al. Clinical profile, comorbidity, and treatment history in 123 hair pullers: a survey study. J Clin Psychiatry. 1995;56(7):319-326.
16. Keuthen NJ, Aronowitz B, Badenoch J, Wilhelm S. Behavioral treatment for trichotillomania. In: Stein DJ, Christenson GA, Hollander E, eds. Trichotillomania. Washington, DC: American Psychiatric Association; 1999:147-166.
17. Wilhelm S, Keuthen NJ, Deckersbach T, et al. Self-injurious skin picking: clinical characteristics and comorbidity. J Clin Psychiatry. 1999;60(7):454-459.
18. Calikusu C, Yucel B, Polat A, Baykal C. The relation of psychogenic excoriation with psychiatric disorders: a comparative study. Compr Psychiatry. 2003;44(3):256-261.
19. Arnold LM, Auchenbach MB, McElroy SL. Psychogenic excoriation. Clinical features, proposed diagnostic criteria, epidemiology and approaches to treatment. CNS Drugs. 2001;15(5):351-359.
20. Fallon BA, Qureshi AI, Laje G, Klein B. Hypochondriasis and its relationship to obsessive-compulsive disorder. Psychiatr Clin North Am. 2000;23(3):605-616.
21. Fallon BA. Pharmacotherapy of somatoform disorders. J Psychosom Res. 2004;56(4):455-460.
22. Josephson SC, Brondolo E. Cognitive-behavioral approaches to obsessive-compulsive related disorders. In: Hollander E, ed. Obsessive-Compulsive Related Disorders. Washington, DC: American Psychiatric Publishing; 1993:215-240.
23. Practice guideline for the treatment of patients with eating disorders (revision). American Psychiatric Association Work Group on Eating Disorders. Am J Psychiatry. 2000;157(1 Suppl):1-39.
24. Kaye WH, Nagata T, Weltzin TE, et al. Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa. Biol Psychiatry. 2001;49(7):644-652.
25. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8-19.
26. Hollander E, Cohen L, Simeon D. Body dysmorphic disorder. Psychiatr Ann. 1993;23(7):359-364.
27. Zimmerman M, Mattia JI. Body dysmorphic disorder in psychiatric outpatients: recognition, prevalence, comorbidity, demographic, and clinical correlates. Compr Psychiatry. 1998;39(5):265-270.
28. Gunstad J, Phillips KA. Axis I comorbidity in body dysmorphic disorder. Compr Psychiatry. 2003;44(4):270-276.
29. Wilhelm S, Otto MW, Zucker BG, Pollack MH. Prevalence of body dysmorphic disorder in patients with anxiety disorders. J Anxiety Disord. 1997;11(5):499-502.
30. Nakamura K, Kitanishi K, Miyake Y, Hashimoto K, Kubota M. The neurotic versus delusional subtype of taijin-kyofu-sho: their DSM diagnoses. Psychiatry Clin Neurosci. 2002;56(6):595-601.
31. Allen A, Hollander E. Body dysmorphic disorder. Psychiatr Clin North Am. 2000;23(3):617-628.
32. Van Ameringen M, Allgulander C, Bandelow B, et al.; World Council of Anxiety. WCA recommendations for the long-term treatment of social phobia. CNS Spectr. 2003;8(8 Suppl 1):40-52.
33. Gunstad J, Phillips KA. Axis I comorbidity in body dysmorphic disorder. Compr Psychiatry. 2003;44(4):270-6.
34. Hudson JI, Pope HG Jr. Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology? Am J Psychiatry. 1990:147(5):552-564.
35. Phillips KA, McElroy SL, Hudson JI, Pope HG Jr. Body dysmorphic disorder: an obsessive-compulsive spectrum disorder, a form of affective spectrum disorder, or both? J Clin Psychiatry. 1995;56 Suppl 4:41-51.